You are here

Glycofi, Inc.

Company Information
Address
Glycofi, Inc. 21 Lafayette St, Ste 200
Lebanon, NH 03766
United States



Information

DUNS:

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Replication of the Human Secretory Pathway in Yeast

    Amount: $731,666.00

    DESCRIPTION (provided by applicant): With its ability to secrete high levels of recombinant proteins, the yeast Pichia pastoris is extensively used for protein manufacturing. However, as actual yield ...

    SBIRPhase II2005Department of Health and Human Services National Institutes of Health
  2. Engineering Glycosylation for Optimal Pharmacokinetics

    Amount: $169,360.00

    DESCRIPTION (provided by applicant): N-Glycosylation has been shown to be a major factor in the overall efficacy of a therapeutic protein. However, the current inability to produce proteins with spe ...

    SBIRPhase I2005Department of Health and Human Services National Institutes of Health
  3. Replication of the Human Secretory Pathway in Yeast

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Although Pichia pastoris is known for its ability to secrete high levels of recombinant proteins, actual yields vary widely for individual proteins. Consequently, ...

    SBIRPhase I2004Department of Health and Human Services National Institutes of Health
  4. Production of Therapeutic Proteins in Lower Eukaryotes

    Amount: $990,410.00

    DESCRIPTION (provided by applicant): Through metabolic engineering of the yeast glycosylation pathway, GlycoFi is developing yeast capable of secreting recombinant proteins with human-like glycosylati ...

    SBIRPhase II2003Department of Health and Human Services National Institutes of Health
  5. PRODUCTION OF THERAPEUTIC PROTEINS IN LOWER EUKARYOTES

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): The pharmacological efficacy of a protein often depends on the protein's glycosylation structure, and successful manufacturing relies on host systems that produce ...

    SBIRPhase I2002Department of Health and Human Services National Institutes of Health
  6. Recombinant protein production in high cell density fermentation of R.eutropha using T7 polymerase system

    Amount: $99,183.00

    Recombinant protein production in high cell density fermentation of R.eutropha using T7 polymerase system: Organophospho compounds are known to include several highly potent cholinesterase inhibitors. ...

    STTRPhase I2001Department of Defense Army
US Flag An Official Website of the United States Government